Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
ALBIREO PHARMA, INC. (ALBO)
Sector: Healthcare; Industry: Biotechnology

Albireo Pharma, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and gastrointestinal disorders. It has a license agreement with EA Pharma for the development and commercialization of elobixibat.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2023-01-23 Graham Michelle Chief Human Resources Officer Sell 102 $43.80 $4,468 No
2023-01-23 Mattsson Jan Chief Scientific Officer Sell 197 $43.80 $8,629 No
2023-01-23 Harford Simon N.R. CFO and Treasurer Sell 102 $43.80 $4,468 No
2023-01-23 Duncan Jason Chief Legal Officer and GC Sell 228 $43.80 $9,986 No
2023-01-23 Cooper Ronald Harold Wilfred President and CEO Sell 1,057 $43.80 $46,297 No
2023-01-23 Carter Martha J. Chief Regulatory Officer Sell 120 $43.80 $5,256 No
2023-01-19 Carter Martha J. Chief Regulatory Officer Sell 938 $43.90 $41,182 No
2023-01-19 Duncan Jason Chief Legal Officer and GC Sell 938 $43.90 $41,182 No
2023-01-19 Mattsson Jan Chief Scientific Officer Sell 3,088 $43.80 $135,254 No
2023-01-19 Graham Michelle Chief Human Resources Officer Sell 1,774 $43.90 $77,886 No
2023-01-19 Harford Simon N.R. CFO and Treasurer Sell 1,776 $43.80 $77,789 No
2022-12-27 Stephenson Pamela Chief Commercial Officer Sell 469 $19.06 $8,940 No
2022-07-22 Stephenson Pamela Chief Commercial Officer Sell 106 $24.67 $2,615 No
2022-10-24 Cooper Ronald Harold Wilfred President and CEO Sell 919 $19.58 $17,991 No
2022-10-24 Stephenson Pamela Chief Commercial Officer Sell 104 $19.58 $2,036 No
2022-10-24 Duncan Jason Chief Legal Officer and GC Sell 656 $19.45 $12,756 No
2022-10-24 Mattsson Jan Chief Scientific Officer Sell 202 $19.58 $3,954 No
2022-10-24 Graham Michelle Chief Human Resources Officer Sell 104 $19.58 $2,036 No
2022-10-24 Harford Simon N.R. CFO and Treasurer Sell 104 $19.58 $2,036 No
2022-10-24 Carter Martha J. Chief Regulatory Officer Sell 104 $19.58 $2,036 No
2022-09-26 Stephenson Pamela Chief Commercial Officer Sell 445 $19.40 $8,635 No
2022-07-22 Mattsson Jan Chief Scientific Officer Sell 205 $24.68 $5,058 No
2022-07-22 Carter Martha J. Chief Regulatory Officer Sell 106 $24.68 $2,616 No
2022-07-22 Graham Michelle Chief Human Resources Officer Sell 106 $24.67 $2,615 No
2022-07-22 Harford Simon N.R. CFO and Treasurer Sell 106 $24.67 $2,615 No
2022-07-22 Stephenson Pamela Chief Commercial Officer Sell 106 $24.67 $2,615 No
2022-07-22 Cooper Ronald Harold Wilfred President and CEO Sell 929 $24.67 $22,923 No
2022-07-12 Harford Simon N.R. CFO and Treasurer Sell 95 $24.03 $2,283 No
2022-06-27 Stephenson Pamela Chief Commercial Officer Sell 461 $19.47 $8,976 No
2022-04-22 Mattsson Jan Chief Scientific Officer Sell 200 $32.92 $6,585 No

Insider Smart

Celldex Therapeutics, Inc. (CLDX) - Multiple insiders including President, EVP, CEO, CSO and Directors bought shares on Jun.9th, first time since 2018, this was very convincing and we initiated a position. Stock soared from $3 to 9$ in 2 days, and the run is still going on.

Insider Smart

VBI Vaccines Inc (VBIV) - Since 10%-owner Perceptive Advisor LCC increased their holding in April, the stock have double the price. Impressive!